Video summary

우리 몸의 미생물로 질병을 치료한다!? 마이크로바이옴 치료제 알아보기!

Main summary

Key takeaways

Science and Nature

Scientific concepts / discoveries / nature phenomena

Microbiome (microbial ecosystem)

  • The microbiome is defined as the sum of microbial genomes in a specific environment—i.e., the full microbial genomic information present there.
  • It includes diverse microorganisms such as bacteria, viruses, and fungi.
  • Microbiomes exist across many body sites, forming microbial ecosystems (examples mentioned: skin, respiratory system, genital region, and vas deferens).

Human microbiome abundance and gene capacity

  • It is stated that more than 90% of microorganisms exist in the human body.
  • The gut microbiome is described as having more than 150× the number of genes compared to human genes.

Functional roles of gut microbes

  • Produce enzymes the human body cannot produce, helping the body absorb nutrients humans otherwise can’t break down.
  • Support vitamin production.
  • Help protect the intestinal lining from pathogens.
  • Influence the brain, emotions, and behavior.

Microbiome imbalance and disease

  • Gut microbes normally help maintain a balanced state.
  • An imbalance (e.g., driven by diet or obesity) can trigger serious or fatal diseases.
  • The microbiome is linked (as stated) to conditions including:
    • Cancer
    • Liver disease
    • Immune disorders
    • Depression

Mechanistic links (as presented)

The summary presents these pathways:

  • Microbiome affects immune function
  • Microbiome generates metabolic substances
  • These changes are presented as mechanisms connecting microbiome shifts to disease

Therapy types / methodologies (classification outlined)

Broadly classified by how the microbiome is utilized:

  • Fecal transplantation
  • Live bacteria
  • Active substances derived from live bacteria (bacteria-derived bioactive products)

Many approaches are also described as falling under probiotics, defined as:

  • Introducing selected bacteria in a live state

Examples / specific claims about therapies and programs

Scale of development

  • According to Korea’s Ministry of Food and Drug Safety (2021), 204 microbiome therapies were reportedly in development worldwide.

Drug example: Reviota (Ferring Pharma)

  • Reviota is described as a bio-innovative drug based on a living microbiome.
  • It is claimed to be the first microbiome-based therapy approved by the FDA in 2022.
  • Intended use: preventing recurrence in adults 18+ treated with antibiotics for recurrent Clostridioides difficile infections (listed in the summary as Clustridium / Clostridioides).

Korea’s national project (2025–2032)

  • The Korean government plans to invest 400 billion won to develop microbiome technologies to address human diseases.
  • Participation: six ministries, including:
    • Ministry of Science and ICT
    • Ministry of Trade, Industry and Energy
    • Ministry of Health and Welfare
  • Project goals:
    • Build a microbiome big data system
    • Develop therapeutic agents
    • Develop diagnostic technologies
    • Perform comprehensive testing
    • Elucidate mechanisms of action
    • Discover candidate substances

Researchers / sources featured (explicitly mentioned)

  • Ministry of Food and Drug Safety (Korea) (2021; cited for global development count)
  • Ferring Pharma (mentioned for Reviota)
  • FDA (referenced regarding Reviota approval in 2022)
  • Korean government / involved ministries:
    • Ministry of Science and ICT
    • Ministry of Trade, Industry and Energy
    • Ministry of Health and Welfare

Original video